Armor Advisors’s Zimmer Biomet ZBH Stock Holding History

Armor Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Buy	151,264 +104,204	+221%	+$9.14M	9.3%	4
2026 Q1	$4.26M	Buy	+47,060	New	+$4.32M	1.43%	10

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Armor Advisors's ZBH Position: Q2 2026 in Review

Armor Advisors increased its Zimmer Biomet (ZBH) stake by 221% in Q2 2026, buying an estimated $9.14M and bringing the position to 151,264 shares worth $13M. The position accounts for 9.3% of the portfolio, ranked #4.

Armor Advisors first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Armor Advisors held 151,264 shares of Zimmer Biomet worth $13M as of Q2 2026.
Armor Advisors bought 104,204 Zimmer Biomet shares in Q2 2026, an estimated $9.14M.
Zimmer Biomet made up 9.3% of Armor Advisors's portfolio in Q2 2026, its #4 holding.
Armor Advisors first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Armor Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.